Travere Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 203
EBIT TTM (mln): -338
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Rok finansowy 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 28 100 134 155 164 175 198 227 212 145 233
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% 254.2% 33.7% 16.0% 6.0% 6.8% 13.1% 14.7% -6.8% -31.5% 60.5%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 98.0% 97.8% 96.6% 97.7% 96.6% 97.0% 96.9% 97.0% 96.4% 61.2% 100.0%
EBIT (mln) -0 0 0 -0 -30 -24 -80 -51 -58 -54 -80 -100 -75 -140 -252 -377 -321
EBIT Δ r/r 0.0% -100.0% 0.0% -inf% 235651.9% -20.7% 232.9% -36.4% 14.7% -7.6% 48.8% 24.7% -24.5% 85.1% 80.3% 49.8% -14.9%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -283.0% -50.8% -43.6% -34.7% -48.7% -56.9% -38.0% -61.3% -118.7% -259.4% -137.5%
Koszty finansowe (mln) 0 0 0 0 0 20 55 8 34 1 10 19 19 20 11 11 11
EBITDA (mln) -0 0 0 -0 -30 -14 -53 -33 -7 -30 -64 -70 -69 -137 -244 -332 -266
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -187.8% -33.2% -5.2% -19.2% -38.8% -39.7% -34.8% -60.3% -115.2% -228.5% -114.0%
Podatek (mln) 0 0 0 0 0 0 -2 -12 -10 1 1 -0 -19 0 0 0 0
Zysk Netto (mln) -0 0 0 -0 -30 -34 -111 117 -48 -60 -103 -146 -169 -180 -278 -111 -322
Zysk netto Δ r/r 0.0% -100.0% 0.0% -inf% 204580.3% 11.5% 228.0% -205.7% -140.9% 24.7% 71.9% 42.6% 15.7% 6.3% 54.6% -60.0% 188.6%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -393.4% 117.4% -35.9% -38.6% -62.5% -83.5% -85.4% -79.2% -131.3% -76.7% -137.9%
EPS -0.0002 0.0 0.0 -0.14 -8.29 -2.38 -4.43 3.49 -1.29 -1.54 -2.54 -3.46 -3.56 -3.01 -4.37 -1.5 -4.08
EPS (rozwodnione) -0.0002 0.0 0.0 -0.14 -8.29 -2.38 -4.43 3.17 -1.25 -1.54 -2.54 -3.46 -3.56 -3.01 -4.37 -1.5 -4.08
Ilośc akcji (mln) 96 0 0 0 4 14 25 34 37 39 40 42 48 60 64 74 79
Ważona ilośc akcji (mln) 96 0 0 0 4 14 25 38 38 39 40 42 48 60 64 74 79
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD